Simultaneously Targeting Obesity and Pain: The STOP Trial

Not Applicable

• Conditions: Chronic Pain; Obesity

• Registration Number: NCT02100995
• Lead Sponsor: University of the Sciences in Philadelphia

Brief Summary

The purpose of this study is to determine whether an integrated behavioral treatment approach can help overweight or obese individuals who also have chronic pain reduce their weight and manage their pain symptoms. The goal of this research is to develop better treatments for individuals with chronic pain and overweight or obesity. All participants in this study will receive treatment for weight management and/or pain symptoms. Participants will be assigned at random (like we picked it blindly out of a hat) to receive either: (1) Standard behavioral treatment for weight loss; or (2) Standard behavioral treatment for pain management; or (3) Integrated behavioral treatment for weight loss and pain.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2014-03-24
• Study First Submitted QC: 2014-03-27
• Study First Posted: 2014-04-01
• Status Verified: 2016-04
• Last Update Submitted: 2016-04-13
• Last Update Posted: 2016-04-15
• Primary Completion: 2017-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Adults aged ≥ 18
• Body mass index (BMI) ≥ 25
• Chronic, non-cancer pain (pain at a level ≥ 4 on a scale of 0-10 on a majority of the days for 6 months or more prior to study participation)

Exclusion Criteria

• Have an unstable medical or psychiatric condition
• Meet criteria for current substance abuse or dependence
• Meet the criteria for bulimia
• Non-fluent in spoken or written English
• Currently pregnant, pregnant within the past 6 months, trying to get pregnant in the next 3 months
• Demonstrate significant cognitive or sensorimotor impairment precluding treatment engagement
• Already participating in a similar structured diet or exercise program or pain self-management program or plans to begin such a program outside the study during the next month
• At risk for significant adverse cardiovascular events with moderate activity
• Plans to relocate within the upcoming 12 months

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Change in pain intensity from baseline to 12 months	Baseline, up to 12 months	Pain intensity as measured on a numeric ratings scale (NRS) of 0 (no pain) to 10 (worst pain imaginable).
Change in weight from baseline to 12-months	Baseline, up to 12 months	Body weight measured using a calibrated digital scale during assessment visits.

Secondary Outcome Measures

Name	Time	Method
Change in pain disability from baseline to 12 months	Baseline, up to 12 months	As measured by West Haven Yale Multidimensional Pain Inventory (WHYMPI).
Change in quality of life from baseline to 12 months	Baseline, up to 12 months	As measured by the SF-36.

Trial Locations

Locations (1)

University of the Sciences; 🇺🇸 Philadelphia, Pennsylvania, United States